Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care (PRiMAL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05254795 |
|
Recruitment Status :
Recruiting
First Posted : February 24, 2022
Last Update Posted : December 14, 2023
|
Sponsor:
Jill M Kolesar
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Jill M Kolesar, University of Kentucky
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | December 2026 |
| Estimated Study Completion Date : | December 2036 |